4.5 Article

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions

Peter G. Arthur et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2008)

Article Oncology

Neural cell adhesion molecule (NCAM) marks adult myogenic cells committed to differentiation

Katie L. Capkovic et al.

EXPERIMENTAL CELL RESEARCH (2008)

Article Neurosciences

N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice

Nicholas P. Whitehead et al.

JOURNAL OF PHYSIOLOGY-LONDON (2008)

Article Multidisciplinary Sciences

Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency

M. Khairallah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding

Jun-Sub Kim et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Pharmacology & Pharmacy

Phosphodiesterase inhibitors

V Boswell-Smith et al.

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Pharmacology & Pharmacy

Muscle damage in mdx (dystrophic) mice:: Role of calcium and reactive oxygen species

Nicholas P. Whitehead et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)

Article Clinical Neurology

Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle

Luc E. Gosselin et al.

MUSCLE & NERVE (2006)

Article Biochemistry & Molecular Biology

Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes

O Basset et al.

BIOCHEMICAL JOURNAL (2006)

Article Biochemistry & Molecular Biology

Anti-TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis

MD Grounds et al.

FASEB JOURNAL (2004)

Article Pharmacology & Pharmacy

Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1

A De Luca et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Article Pharmacology & Pharmacy

Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle

TJ Bloom

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)

Article Rehabilitation

Oxidative stress and the pathogenesis of muscular dystrophies

TA Rando

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2002)

Article Biochemistry & Molecular Biology

Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology

MJ Spencer et al.

HUMAN MOLECULAR GENETICS (2002)

Article Biochemistry & Molecular Biology

Use of N,N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma

V Verde et al.

FREE RADICAL RESEARCH (2002)

Review Pharmacology & Pharmacy

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

EP Hoffman et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2001)

Article Clinical Neurology

Pre-clinical screening of drugs using the mdx mouse

JA Granchelli et al.

NEUROMUSCULAR DISORDERS (2000)